A phase II trial of oxaliplatin, cytosine arabinoside [cytarabine], dexamethasone with rituxan [rituximab] (ROAD) in patients with relapsed CD20+ B-cell non-Hodgkin's lymphoma
Phase of Trial: Phase II
Latest Information Update: 01 Oct 2017
At a glance
- Drugs Rituximab (Primary) ; Cytarabine; Dexamethasone; Oxaliplatin; Pegfilgrastim
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 01 Oct 2017 Results published in the American Journal of Hematology
- 30 Oct 2015 Status changed from suspended to completed.
- 04 Aug 2008 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.